UNASSIGNED:干细胞研究(SCR)和再生医学(RM)的突破引起了全球公众的广泛关注。同时,科学界和科学政策试图建立对SCR和RM的适当治理。在这种情况下,科学界与公众之间的有效沟通被视为关键因素。然而,公众态度和利益的多样性没有得到充分审查,尤其是各国之间的差异。
UNASSIGNED:我们对公众对SCR和RM的态度进行了国际比较。我们在六个国家的人群中分发了一份互联网问卷:日本,韩国,美国,英国,德国,和法国。我们从每个国家收集了100个有效的回复,共获得600份回复。
未经评估:我们的主要发现是RM利益的多样性,可以表达为用户实用主义,RM的治理和处理,风险,和利益,和科学利益。六个国家的利益优先次序各不相同,这些变化可能会受到政治因素的影响,社会,文化,以及每个国家SCR和RM的媒体背景。
UNASISIGNED:其含义可以有助于更深入地了解公众态度的多样性,并在全球范围内适当审查SCR和RM的广泛道德和社会关切。
UNASSIGNED: Breakthroughs in stem cell research (SCR) and regenerative medicine (RM) have attracted significant public attention worldwide. Simultaneously, scientific communities and science policies have tried to establish appropriate governance of SCR and RM. In this context, effective communication between scientific communities and the public is regarded as a key factor. However, the diversity of public attitudes and interests has not been sufficiently examined, especially the differences across countries.
UNASSIGNED: We conducted an international comparison of public attitudes toward SCR and RM. We circulated an internet questionnaire among people in six countries: Japan, South Korea, the United States, the UK, Germany, and France. We collected 100 valid responses from each country, and a total of 600 responses were obtained.
UNASSIGNED: Our key findings are the diversity of interests in RM, which can be expressed as user pragmatism, governance and handling of RM, risk, and benefit, and scientific interests. The priority of interests varied across the six countries, and the variations may be influenced by the political, social, cultural, and media contexts of SCR and RM in each country.
UNASSIGNED: The implications can contribute to a deeper understanding of the diversity of public attitudes, and bring about an appropriate examination of a wide range of ethical and social concerns of SCR and RM in global contexts.